Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Team effort: Naomi Petela, Thomas Gligoris and Johanna Scheinost from the Nasmyth lab
Team effort: Naomi Petela, Thomas Gligoris and Johanna Scheinost from the Nasmyth lab

Malarial proteinA new study fills in the gaps in our understanding of a protein complex that traps DNA during cell division until the critical moment just before the daughter cells separate. The researchers behind the work, from Kim Nasmyth's lab in the Department of Biochemistry and the lab of Jan we at the MRC LMB in Cambridge, describe their findings in a recent paper in Science (1). Using new structural information about how the individual components of the cohesin complex fit together, the group has confirmed in living cells what has been suspected to be the case - that the complex adopts a ring structure that holds the two arms of the chromosome together until exactly the right moment in cell division. Researchers can now begin to probe the mechanisms behind cohesin's functions.

Read more (Department of Biochemistry website)

Image: Newly solved crystal structure of part of the cohesin complex

  1. 'Closing the cohesin ring: structure and function of its Smc3-kleisin interface.' Gligoris, TG, Scheinost, JC, Burmann, F, Petela, N, Chan, K-L, Uluocak, P, Beckouet, F, Gruber, S, Nasmyth, K and Lowe, J. Science (2014) Vol. 346 no. 6212 p963-967.

Similar stories

Regular meat consumption linked with a wide range of common diseases

Research

Regular meat consumption is associated with a range of diseases that researchers had not previously considered, according to a large, population-level study conducted by a team at the University of Oxford.

New data show vaccines reduce severe COVID-19 in older adults

Coronavirus COVID-19 Research

New data show both Oxford / AstraZeneca vaccine and the Pfizer-BioNTech vaccines significantly reduce severe COVID-19 in older adults.

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

Coronavirus COVID-19 General Research

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.